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Abstract 
 
Zachary McDonald: Exploring the Feasibility of the Expansion  
of Social Prescribing in the United States: A Policy Analysis 
 
(Under the direction of Sue Tolleson-Rinehart, PhD) 
 
Consideration of patients’ social needs is a chief element of comprehensive primary care, 
as articulated by multiple American professional societies. A new model of community referral 
from the primary care setting, known as social prescribing, originated in the United Kingdom 
and seeks to standardize and expand the availability of this longstanding practice. I interviewed 
three key stakeholders to determine the series of conditions under which an expansion of social 
prescribing schemes in the United States would be most feasible and for which populations it 
could be most advantageous. Preliminary results of these interviews confirm the presence of a 
diverse set of social needs intervention models in the United States. Interestingly, the term social 
prescribing has not been widely adopted to refer to American programs that share its core 
features, as the moniker has not gained wide traction in this country to date. My findings indicate 
that community health centers (CHCs) are best positioned to serve as sites of future pilot projects 
utilizing the social prescribing model in the United States. CHCs are more likely to serve 
socioeconomically disadvantaged clients and have pre-existing, sophisticated relationships with 
the community sector required for such schemes. My recommendations include increased 
international efforts to develop American experts in this area and the identification of American 
physician advocates for the implementation of social prescribing in well-resourced communities 
to lead explorations of its feasibility within their local contexts.  
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 1 
Introduction 
Psychosocial stress is linked to poor mental and physical health outcomes and often 
stems from unmet social needs (Schneiderman et al. 2005). Patients are increasingly turning to 
primary care clinicians for solutions to their social needs, such as food insecurity, unsafe 
housing, unemployment, or turbulent interpersonal relationships. However, physicians and other 
clinicians have not historically possessed the resources necessary to address the social 
determinants of their patients’ health directly. Social prescribing is an emerging model of 
clinical intervention wherein providers “prescribe” community resources to patients in response 
to their stated social needs (Drinkwater et al. 2019). These schemes are also referred to in the 
literature as community referral or community linkage. The most prominent program model uses 
skilled link workers stationed in medical practices to identify and connect patients to the most 
appropriate community resources. Programming to which patients may be referred is diverse and 
dependent on the activities available in a community’s particular voluntary sector. They may 
include, for example, group exercise, art, or culinary classes, guided nature walks, job training, 
new skills acquisition, bereavement groups, or chronic illness support groups.  
Effectiveness and cost-effectiveness research on social prescribing interventions remains 
in its infancy. A number of observational studies and independent program evaluations of social 
prescribing schemes in the United Kingdom have demonstrated modest yet significant 
improvements in outcomes such as anxiety, depression, and well-being (Grant et al. 2000; Friedli 
et al. 2004; Dayson et al. 2014). In response to these and other data and high patient demand for 
these programs around England, National Health System leadership announced its Long Term 
Plan to make access to social prescribing universal in England by 2023 (Drinkwater et al. 2019). 
Inspired by the British, experimental programs have been developed in Canada, Australia, New 
 2 
Zealand, and Scandinavia. A handful of social prescribing-like pilots are active in the United 
States, but none yet rival the sophistication of England’s schemes (Alderwick et al. 2018). 
One of the British government’s stated reasons for supporting the proliferation of social 
prescribing programs is to address social determinants of health, such as the sizable public health 
threat posed by social isolation. Isolation has been associated with detrimental health behaviors 
like smoking, physical inactivity, and even early mortality (Cacioppo et al. 2002; Holt-Lunstad 
et al. 2015). Social isolation is defined as having “a minimal number of social contacts” leading 
one to be “deficient in fulfilling and quality relationships” (Nicholson 2012, 137). It is often 
considered a function of the constraints introduced by one’s environment, or aspects of one’s 
identity that may render one marginalized within one’s community. Social isolation has 
commonalities with but is considered distinct from loneliness, which is at base an emotional state 
independent of one’s physical proximity to others. Socially isolated individuals are more likely 
to utilize healthcare services than are individuals who feel socially connected; in fact, general 
practitioners in Britain report that over 20% of patient visits are chiefly for psychosocial 
complaints (Davidson and Rossall 2015).  
  Community referrals made via a social prescribing mechanism are engaging and 
participatory by definition, introducing a patient to the new setting of a community resource, as 
well as to other clients utilizing a resource concomitantly. One may anticipate, therefore, that 
social prescribing could improve participants’ subjective sense of social isolation if pursued for 
this purpose. While qualitative interview data is primarily being used by British health officials 
to justify the universal expansion of social prescribing within its primary care services, it remains 
unclear whether there is strong quantitative evidence to support social prescribing’s capacity to 
improve social isolation. From a policy perspective, what is the specific utility of codifying and 
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expanding existing clinical social needs programs as social prescribing interventions? Moreover, 
in which clinical settings and for what specific populations would this clinical workflow 
modification be the most meaningful? The following analysis seeks to explore these questions, 
using the state of North Carolina as a frame of reference from which to consider the feasibility of 
its implementation.  
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Theoretical Perspective 
 
 The relevance of social needs, such as one’s ability to earn a living wage, maintain secure 
housing, and access proper nutrition, is increasingly recognized as influencing the capacity to 
maintain physical and mental health. Unmet needs in this area may also reduce the ability to 
participate in a plan of care arrived at in consultation with a primary care provider for a co-
existing medical condition. From the societal perspective, the aforementioned social needs and 
an array of other issues comprise the social determinants of health. Although population-level 
interventions are considered most promising for addressing these determinants, intervening at the 
community level also has a limited but important role, as interventions can be personalized to the 
most urgent needs. The cultivation of this type of micro-environment that is responsive to the 
needs of its citizens can act to promote community cohesion and resilience. 
 The social ecological model based on the work of Urie Bronfenbrenner considers one’s 
health status as inseparable from his or her social context (McLeroy et al., 2003). When an 
individual demonstrates maladaptive health behaviors or expresses concern that he or she faces 
environmental constraints such that one or more unmet social needs prevents them from 
presently participating in healthier behaviors, interceding at the level of the clinical health 
interaction may be a fruitful approach in individuals that routinely utilize health services in their 
community. Intervention at this level of analysis may overflow into other areas and may function 
to deepen local social networks, reduce trauma in childhood (perhaps due to safer housing), and 
could even reduce violent crime. Over time and at scale, community referral can clarify the most 
pressing needs of a community’s residents, which can inform local political activism. 
 The Center for Disease Control and Prevention’s Task Force on Community Preventive 
Services works to advance community-level interventions for health. The body has concluded 
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these initiatives in general have the capacity to “reduce the persistent disparities in health related 
to socioeconomic status, education, and housing” (Anderson et al. 2002, 1). Homelessness in 
particular has a well-characterized negative effect on health. Indeed, homeless individuals have 
4-fold higher odds of mortality compared to individuals in housing (O’Connell 2005).  
 In the future, data analysis of electronic medical records tracking utilization of 
community resources accessed via a social prescribing mechanism can help predict which 
patients are likely to become “super utilizers” of healthcare resources and flag them for 
preemptive outreach by a case manager or clinical social worker. Addressing pressing social 
needs can also be seen as a preventive action and has the potential to yield cost savings to the 
healthcare system if a fulfilled need enables one to avoid a deterioration in health. Quantification 
of the effect in healthcare utilization, including hospitalizations and emergency room visits, may 
inform future decision-making in this area. In the shorter term, link workers must be judicious 
about the community assets to which clients are referred and be proactive about maintaining the 
voluntary sector relationships presently at their disposal. Frequency and quality of resource 
utilization should be evaluated via follow-up calls with clients, and a flexible approach should be 
adopted that encourages clients to pursue a different resource if their need is being unmet. 
 
Findings from the literature 
 
 My original review of the literature for this project focusing on the outcome of social 
isolation was largely inconclusive. A full discussion of the results of my systematic review can 
be found in Appendix A. To summarize, I conducted a limited systematic review on the effect of 
social prescribing interventions on participants’ rating of their social isolation. I conducted full 
text review of seven articles and found no clear direction of effect on social isolation after taking 
part in a social prescribing referral intervention. The overall strength of this evidence is low.   
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Methods 
 
 I triangulated multiple methods to best characterize the feasibility of the expansion of 
social prescribing schemes in the United States. First, I conducted a limited systematic review of 
the literature on the capacity of social prescribing to improve social isolation. This outcome is of 
key interest to stakeholders in this area and is often cited as one of the main public health threats 
that has animated the proliferation of social prescribing in the United Kingdom. The methods 
and full results of this review can be found in Appendix A. This present paper is based on the 
first three in-depth interviews with stakeholders I was able to reach at the time of this writing in 
order to contextualize the status of the implementation of this model of community referral in 
North America generally, and the United States specifically. 
The Institutional Review Board of the University of North Carolina determined that my 
research was “not human subjects research” and exempt from further review (IRB # 19-0533); 
after receiving this approval, I contacted prospective interviewees using a standardized invitation 
email introducing myself and explaining the aims of my research project (Appendix B). I 
requested their participation in an interview via phone or videoconference given they were each 
located remotely. My choice of interview respondents was grounded primarily in a Web search 
of the leading experts in this field. I subsequently sent several more interview invitations after 
being connected to additional experts by my initial interview respondents, in the normal “rolling 
reputational” process of identifying further experts. 
I interviewed all three respondents whose comments are analyzed here by phone, after 
receiving verbal consent to be interviewed, to record the conversation, and to refer to them by 
name and title in my work. Interviews were conducted between May 22, 2019 and June 5, 2019. 
I used the interview guide in Appendix B as a template to begin the interviews and employed 
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standard interview techniques. I recorded each interview using the Tape A Call smartphone 
application to ensure accurate representation of responses. I manually transcribed all interviews 
verbatim. 
 
 
Results 
 
 I interviewed one American and two Canadian professionals who are actively overseeing 
social prescribing pilot programs and act as thought leaders in this policy space. All stakeholders 
agreed to be identified by name and title, although one informant requested not to be quoted 
directly in my work. The interview respondents, including their professional positions, 
nationalities and the order in which they were interviewed, can be found in Table 1. I pursued the 
Canadian perspective because of its geographic and cultural proximity to the United States and 
given that its health officials are actively mentoring American counterparts on how to translate 
these schemes to the American context. After speaking with them, my future plans for this work 
include seeking a more local perspective (North Carolina/Triangle level) to determine the present 
awareness of social prescribing and discuss the feasibility of its implementation locally. 
 
Commentary on social prescribing in the American context 
 
 Interview respondents shared many common views about the utility of social prescribing 
interventions. One informant believes that there are many models by which social needs can be 
intervened upon, including but not limited to social prescribing. Another was unreservedly 
optimistic about social prescribing’s capacity to address the needs of American patients. They 
both identified these kinds of services as fundamental elements of quality primary care as 
identified by prominent professional organizations. They both also said that the use of a more 
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holistic framing of patients’ health, rather than seeing health purely through a medical lens, can 
aid clinicians’ understanding of which patients could be served by community linkage.   
 One chief officer at a large health care non-profit organization underscored that the social 
prescribing model is still being refined and expressed the need for its definition to be more 
properly bounded so that there can be a common understanding of what that term refers to in the 
literature. While his organization supports many clinical operations that use link workers to refer 
to community resources, they have not yet labeled these programs social prescribing. He said 
one challenge is that most clinics do not have additional funds to hire a full-time link worker to a 
care team, but many existing staff (e.g., social workers, care managers, therapists) are already 
serving this role in an unofficial capacity. Alternatively, he cited an example from the Boston 
area in which local college students volunteer to serve in shifts as link workers at a community 
clinic, drawing on an integrated resource database. This example illustrates that link workers 
must not necessarily be single, discrete individuals to function well in the referral pathway. 
 This officer also said that referrals that may fall under the social prescribing umbrella can 
be ordered under other existing models of care in the United States, such as the chronic care 
management model in Medicare. Its billings codes are flexible to the extent that community 
linkage activities deemed necessary by the clinician can be covered. Finally, this officer drew a 
distinction between the robust social interventions that are possible in health care systems that 
bundle public health and healthcare spending, such as Costa Rica and New Zealand. This 
bundling makes for a more robust community sector in which universal access to community 
interventions for its population may render moot the need to make referral to these activities 
from a clinical interaction. He cites the Center for Medicare and Medicaid Innovation as a body 
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working to find effective models to compensate for the fact that this integrated approach has not 
been historically present in the United States.  
Last, he encouraged a reconsideration of the need for a specific type of evidence to justify 
spending to increase access to social needs interventions, as it is often impossible to conduct a 
study over the time horizon necessary to assess long-term outcomes resulting from engagement 
with a particular resource. He would like to see greater visibility of the stories of the lived 
experiences of community residents who are participating in and benefitting from social 
prescribing-like interventions considered by policymakers in this area, in addition to the 
quantitative data that has historically been given ultimate weight. 
 
Lessons from Canada 
 
 Two participants shared how their experiences directing the implementation of nearly 
two dozen social prescribing pilots across the Canadian province of Ontario may be instructive 
for the United States. They have built a comprehensive evaluation into the design of the pilots 
and are beginning to compile the results for multiple outcomes, including physical and mental 
health, sense of belonging, resilience, and the provider experience of referral. Nearly all their 
pilot sites are community health centers (CHCs), and all but one center primarily utilize referrals 
to resources existing within the clinic itself. Multiple sites have designed specific interventions 
for their patients within the clinic, such as bereavement groups and Alzheimer’s support groups, 
as a direct response to patient demand. This approach also helps ensure that transportation or 
other costs do not impede patients’ participation in the resources. They emphasize that the 
diversity of their province is such that social needs resources may vary widely by clinic. For 
example, while one site responds to the needs of a rural Francophone population in the north, 
another has special programming for LGBTQ populations in urban Toronto. 
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These informants are engaged in disseminating their knowledge about how to best 
implement social prescribing to a handful of officials at state health associations in the United 
States. Dr. Mulligan explained her reasoning for believing social prescribing could easily be 
translated to the American system by citing recent news that Kaiser Permanente will launch 
Thrive Local, a comprehensive social health network. “It seems like it will leapfrog ahead of 
what we’re able to do just because of the sheer scale of it…It would just be structured 
differently…Not to mention, you’ve got a robust community health sector, way better than ours,” 
she said. 
She described the initial approach she believes American actors in this space should take 
when considering implementing a social prescribing pilot and how to best communicate what 
clinics are finding out about of the needs of its patient populations. 
They just need to make a connection with the services they already provide and evaluate 
it and report back in the kinds of trends that health systems folks understand. Because for 
the longest time we’ve been using health promotion and community development 
language that doesn’t necessarily resonate with the clinical world, and for economic, 
government decision-making. 
She qualified her optimism by stating that the pilot programs she directs were only made 
possible by the opportune availability of special funding from the Canadian government. 
“It [original pilot project] emerged from our work on this thing called the Canadian 
Index of Well-Being, which was an attempt by some Canadian community groups and 
academics to come up with an alternative to GDP, to measure how we’re doing as a 
society…We happened upon a grant opportunity through the Ministry of Health and 
Long-term Care here in Ontario, and we used that to launch this pilot.”   
The discussion and conclusions to follow result from my understanding of these first three 
interviews. Additional interviews may change the picture these stakeholders have created. 
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Discussion 
 
My preliminary results reveal promising clinical contexts within which to apply wider 
access to a social prescribing mechanism in the United States. The findings of Ontario’s pilot 
programs are forthcoming, likely in 2020, and will be instructive about whether social 
prescribing successfully translates out of the British context. New efforts toward international 
dialogue between health care professionals on this issue are likely to promote increased 
consideration by potential adopters of this model. Policymakers should take care, however, not to 
consider this model as a panacea to address the social determinants of health, especially in a 
country as large and diverse as the United States. Even where universally available, the solutions 
to these issues are likely structural, resulting from federal policies that affect the economic 
vitality, the quality and accessibility of health care, and the general well-being of populations. 
Some posit that a more liberal social safety net, such as a universal healthcare scheme, could 
reduce some of the psychosocial stressors that may lead patients to pursue social prescribing 
referral in the first place. Given the status of existing state and federal policy, however, the 
implementation of a social prescribing mechanism is likely feasible in specific corners of our 
nation’s primary care services. Implementation efforts will require the time commitment of 
dedicated staff members, as well as efforts to acquire grant funding to cover the costs of program 
planning and evaluation. The formation of a network of American facilitators of the social 
prescribing model could support these actors in areas that lack local pilot programs. Replicating 
the level of policy support for social prescribing that is present in the United Kingdom will 
require the vocal advocacy of clinicians who work with patients with complex social needs in 
their daily practice. These physician advocates must also synthesize compelling aspects of the 
existing evidence base and their clinical experiences to shape an argument to stakeholders. 
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Conclusion 
 
The universal adoption of a standard model by which clinicians can intervene on social 
needs would elevate the prominence of these services and promote the visibility of these 
offerings in the clinical setting. It would also allow for a more robust conversation among public 
health professionals and researchers in this area who are tasked with devising appropriate 
methodologies to evaluate whether social prescribing schemes can deliver on the aims that its 
proponents have articulated. The question of within which type of primary care clinical 
environment it is most appropriate to pursue this type of expansion in the American context is of 
immediate salience. Based on my findings, community health centers (CHCs) are best positioned 
to adopt the social prescribing model. These centers are likely to have pre-existing and 
sophisticated relationships with partners in the community sector and are also more likely than 
other type of practices to have active resources within the clinic itself (such as illness support or 
education groups), which would lower the barrier to entry to participation by its patient 
population. To this end, I recommend that the leadership of state community health center 
organizations, such as the North Carolina Community Health Center Association, identify its 
clinical sites with the most robust resources as sites within which this model could be most easily 
adopted. A committee of state health center officials should then be convened to determine an 
implementation plan, which would include the categorization of available resources, the 
identification of existing staff that could take on the “link worker” role, the creation of a plan to 
educate providers and promote patient awareness of this model, and, critically, the conception of 
an evaluation methodology which include a set of outcomes most relevant to its early utilizers. 
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Tables and Figures 
 
Table 1. List of interview respondents in chronological order of interview. 
 
Respondent Professional Position Nationality 
Dr. Damon Francis Chief Medical Officer 
Health Leads non-profit organization 
Boston, MA 
*Not quoted directly by request 
United States 
Dr. Kate Mulligan Chief Policy and Communications Officer 
Alliance for Healthier Communities 
Ontario, Canada 
Canada 
Sonia Hsiung Social Prescribing Pilot Lead  
Alliance for Healthier Communities 
Ontario, Canada 
Canada 
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Appendix A –  Systematic Review of the Literature 
 
The Effect of Social Prescribing on Social Isolation 
 
Abstract 
Aim of study:  To perform a systematic review of the literature to evaluate the effect of 
social prescribing schemes on social isolation, which represents a growing 
threat to public health and well-being in high-income countries. 
 
Method(s):  I searched multiple databases (PubMed, Scopus, Cochrane) for 
randomized trials, observational, pre/post evaluations, and qualitative 
interview studies published from 2000 to present that report social 
isolation as an outcome. Eligible studies included adults aged 18 and over, 
a follow-up period of ≥ 3 months and a referral pathway from primary 
care or GP practices to the voluntary sector. I graded the strength of the 
evidence of each study using NIH tools. 
 
Results:  A total of 6 studies were included (n=605). In one RCT (n=161), there was 
no difference between baseline and 4 months on the confidant and 
affective support scales of the Duke-UNC Functional Social Support 
Questionnaire (p=0.221 and 0.594, respectively). The results of 4 pre/post 
survey studies (n=420) were mixed. One study (n=69) demonstrated a 
significant improvement in isolation measured by the Friendship Scale 
(p<0.001; ETA 0.4) while 3 others (n=351) found no difference. One 
qualitative interview study (n=24) found no difference. 
 
Conclusion:  This first-of-its-kind review clarifies the state of the evidence regarding 
the capacity of social prescribing programs to improve social isolation. A 
minority of studies included isolation as an outcome. Methodological 
heterogeneity, modest sample sizes, and the broad diversity of 
interventions evaluated render the quality of the evidence as poor. Given 
our growing understanding of the burden of suffering posed by isolation, 
researchers should adopt a standardized approach to measuring social 
isolation in order to more accurately quantify post-intervention effects. 
Use of validated tools such as the Duke Social Support Index or the Social 
Disconnectedness Scale would enable comparison of outcomes among 
studies and allow for more robust decision-making by policymakers. 
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Introduction 
Community-level interventions to address social needs are relatively common. A 
prominent clinical model being advanced in the United Kingdom and other high-income 
countries to help patients address their social needs is called “social prescribing.” When a patient 
visits a primary care provider and shares that he or she has a particular social need, clinical 
settings with active social prescribing programs can refer the patient to a trained link worker, 
who will connect the patient with relevant community resources. While recent studies suggest 
that the evidence base to support social prescribing is mixed, and fairly weak overall, pilot 
programs continue to proliferate in many Western countries. It is being considered a partial 
solution to address specific social determinants of health in the U.K., where health officials seek 
to improve social isolation and other markers of social connectedness within its population. 
Recent data suggest is a significant threat to public health in Britain and other HICs. 
Social isolation has negative consequences for health and has been associated with 
increased rates of dementia, heart disease, and depression (Valtorta et al. 2016; James et al. 
2011; Cacioppo et al. 2006). While data show that isolation impacts all age groups in the U.K., 
young adults and the elderly have the highest burden of suffering from this social condition. Of 
the elderly over age 75, the prevalence of living alone has increased by 24% in the last 20 years 
to 2.2 million seniors (Office for National Statistics UK). Overall, over 1.2 million British older 
adults are chronically isolated, according to a 2016 Age UK study. The prevalence of social 
isolation is also high in the United States. Twenty-two percent of Americans endorsed feeling 
socially isolated in a large-scale survey by the Kaiser Family Foundation, with a majority of 
these respondents being under age 50 (DiJulio et al. 2019). Moreover, a 2016 Cigna survey 
revealed that 53% of Americans do not have meaningful social interactions on a daily basis and 
 18 
identified Generation Z (ages 18-22) as the most isolated in America (Cigna 2016). Given the 
concerning nature of these and other data, clinicians and public health professionals are working 
to determine whether existing clinical or social interventions could match the scale of this 
problem. Public health professionals in the United States are beginning to look at the capacity of 
social prescribing programs to address this issue. Introducing this model to the American context 
has unique challenges, however, as is it a much larger country, a different healthcare system, and 
community resources tend to vary quite substantially by city and state. 
The aim of my partial systematic review is to appraise the evidence for whether social 
prescribing interventions by primary care providers improves patients’ subjective sense of social 
isolation. This study will be the first review on social prescribing to assess this outcome. The 
results of this review will serve to inform policy makers in this area and identify methodological 
areas for improvement on this outcome. 
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Methods 
 
 
Scope of review 
 
This review aimed to assess the evidence in regard to the capacity of social prescribing 
programs to reduce participants’ social isolation. I adhered to the PRISMA checklist for 
systematic reviews when conducting this review. This study was not registered. 
 
Eligibility criteria 
 
I reviewed published literature as well as independent program evaluation reports that 
met the following eligibility criteria (Table 1): (1) participants were adults 18 years of age or 
older; (2) intervention was labeled as or met the definition of a “social prescribing” or 
“community referral” program that enrolled patients primarily through PCP referral (i.e. utilized 
link worker, referred patients to voluntary sector programming, etc.); (3) pre-intervention social 
isolation metrics OR usual care used as the comparator; (4) post-intervention isolation metrics as 
outcome of interest; (5) a follow-up period of >3 months prior to assessment of outcome; (6) a 
primary care or general practitioner (GP) practice setting in any country (although these 
programs primarily operate in English-speaking HIC); and (7) English language articles since the 
year 2000, since social prescribing pilot programs began in the late 1990s in the United 
Kingdom, and program evaluations did not begin until a year or so thereafter. Due to the limited 
amount of available literature on this topic, I chose not to exclude any specific study designs 
from this review so as to maximize the potential number of studies eligible and enable a 
thorough assessment of the state of the literature on social prescribing for our outcome. 
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Search strategy 
PubMed, Cochrane, and Scopus databases were searched for eligible studies. I utilized 
the following search criteria for all searches: (Social prescribing OR social prescription OR 
community referral OR non-clinical prescribing OR non-medical prescribing) AND (social 
isolation OR isolation OR loneliness OR lonely OR connectedness OR connection). Specific 
hedges used to identify distinct study designs were utilized for the PubMed database, as detailed 
in Table 2. I searched ClinicalTrials.gov for unpublished studies on our topic as well as 
performed a Web search for relevant grey literature. All searches were conducted between 12 
March and 15 March 2019. Studies will be selected for inclusion based on whether they meet 
inclusion criteria (Table 1). 
 
Study selection and data abstraction 
For articles that met inclusion criteria following full-text review, I abstracted a variety of 
information, including setting, study design, intervention and comparison groups, sample size 
and characteristics (i.e. age range of participants, presence of psychiatric or medical 
comorbidities, etc.), outcomes, and measurement tool utilized for the social isolation outcome. I 
grouped two articles with findings from the pre- and post- results of a single discrete study. 
Summary measures varied and included percent change or P value data from pre/post 
intervention or RCT outcome data, in addition to “direction of effect” descriptive data based on 
the results of qualitative studies. I sought to derive a general interpretation of effect from these 
data using quantitative and qualitative synthesis strategies. 
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Results 
Study selection  
 
I identified 589 unique articles and assessed 29 full-text articles for eligibility. 
Specifically, our PubMed search identified 496 articles, and the Scopus search yielded 12 
articles. An additional five reviews were identified in the Cochrane database search, for a total of 
513 records identified via database search. None of the 67 unpublished studies found in our 
search of ClinicalTrials.gov met inclusion criteria. Nine additional records were found by 
searching the Web for grey literature. All 582 articles remaining following the removal of 
duplicates underwent abstract review, resulting in the exclusion of 553 articles. I then performed 
full-text review on 29 records. From this process, 22 articles were deemed ineligible for various 
reasons, as detailed in the PRISMA diagram in Figure 1. The remaining 7 articles (6 studies) 
underwent data abstraction for inclusion in this systematic review.  
 
Direction of effect 
 The overall direction of effect could not be determined from this set of studies. The 
overall strength of the evidence is low. Description of the characteristics and results of each 
study for the social isolation outcome, including their study designs, sample sizes, and follow-up 
times can be found in the Evidence Table (Table 3). The manner in which social isolation was 
assessed by study can be found in Table 4. I did not perform subgroup analysis or meta-analysis 
due to concern the results of such analyses would be unreliable. 
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Discussion 
 
 My review found inconclusive evidence that social prescribing programs can reduce 
social isolation in their participants. The overall strength of the evidence is low. Although a 
majority of studies led to significant or non-significant reductions in social isolation, a 
conclusion toward this direction of effect cannot be responsibly made. Despite this finding, this 
study is the first review of its kind to evaluate the effect of this emerging model of social 
intervention on isolation, an increasingly relevant public health outcome. 
 This review has several limitations. Multiple methodological shortcomings increase the 
risk of bias both within and across the included studies. Moreover, the overall quality of the 
studies assessed is low. All studies described British schemes and targeted socioeconomically 
disadvantaged areas. All but one study utilized a relatively weak pre/post design to measure 
effects on the outcome. Sample sizes were quite varied but were small on average. In two 
studies, representations of data are such that the reader cannot determine how the results for 
isolation were measured and/or calculated. The studies also generally fail to provide data on the 
utilization rates of various resources, rendering it impossible to determine which resources were 
best able to promote social connectedness. 
 I placed special attention on the methodologies used to measure social isolation in each 
study. While Grant et al. and Kimberlee used well-validated tools, other studies asked subjects 
about their connectedness to others, or even simply about their mental health in general. These 
latter methodologies are too weak to contribute meaningfully to the determination of a direction 
of effect. I chose to retain them in this review because they are demonstrative of the 
shortcomings inherent in how the isolation outcome is measured in social prescribing literature.  
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My recommendations for future research in this area include the need to select validated 
tools to measure isolation in program evaluations where this outcome is of interest. In addition to 
the UNC-Duke Functional Social Support Scale and the Friendship Scale, two additional 
validated tools with utility for this outcome include the Duke Social Support Index and the 
Social Disconnectedness Scale. These latter two tools include especially nuanced questions that 
seek to characterize the depth of the social network and the frequency of contact with others, 
which may help clinicians pinpoint which community resource may best intervene for one’s 
need. Over time, the adoption of a standard tool used universally for this outcome will enable 
comparison among studies. In addition, more rigorous designs, such as the randomized trial 
elegantly employed by Grant et al., should be utilized by other pilot program evaluation teams. 
The presence of a control group receiving routine care is an important advantage of the RCT and 
enables direct contrast of outcomes with those participating in the intervention arm. 
 This review indicates that social prescribing’s effect on isolation remains unclear. The 
United Kingdom’s substantial investments in social prescribing cannot be justified by this 
evidence alone. Given the growing burden of social isolation, however, it is critical that the 
public health community continue to evaluate interventions that target this insidious issue. 
Researchers should continue and expand plans to evaluate social prescribing pilots outside of the 
United Kingdom in order to see whether a reduction in isolation is seen outside of the British 
context. I also believe the term social prescribing fails to capture qualifying interventions during 
searches of the literature. The broader codification of social needs interventions utilizing a link 
worker and community linkage as being social prescribing programs will identify existing 
schemes that should be included in reviews seeking to determine the capacity to reduce isolation. 
 
Funding: There were no sources of funding for this review. 
COI: No conflicts of interest to disclose. 
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Tables and Figures 
 
Table 1. Eligibility criteria 
 
Category Inclusion criteria Exclusion criteria 
Population Adults ≥ 18 years  Children and adolescents <18 years 
Intervention 
“Social prescribing” or “community 
referral” intervention enrolling patients 
via PCP referral 
All social prescribing interventions not 
utilizing PCP referral as predominant 
enrollment method 
Comparator 
Pre-intervention measurement/rating of 
social isolation OR usual care/no 
intervention 
____ 
Outcome  
of interest 
Post-intervention measurement/rating of 
social isolation (or substitute metric) All other outcomes 
Timing  Follow-up periods of ≥ 3 months Follow-up periods of <3 months 
Setting(s) Primary care or GP surgery All other clinical setting types  
Study 
design(s) 
Systematic reviews, RCTs, observational 
studies, pre/post evaluations, qualitative 
studies 
____ 
Language English language articles Non-English language articles 
Years 
considered 2000 to present Prior to 2000 
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Table 2. Search strategy utilized for PubMed database. 
 
PubMed (Date searched: 3/12/19) 
Search Query Results 
1 (Social prescribing OR social prescription OR community referral OR non-clinical 
prescribing OR non-medical prescribing) AND (social isolation OR isolation OR 
loneliness OR lonely OR connectedness OR connection) 
496 
2 1 AND ((randomized[title/abstract] OR randomised[title/abstract]) AND 
controlled[title/abstract] AND trial[title/abstract]) OR (controlled[title/abstract] 
AND trial[title/abstract]) OR "controlled clinical trial"[publication type] OR 
"Randomized Controlled Trial"[Publication Type] OR "Single-Blind Method"[MeSH] 
OR "Double-Blind Method"[MeSH] OR "Random Allocation"[MeSH] 
23 
3 1 AND ("review"[Publication Type] AND "systematic"[tiab]) OR "systematic 
review"[All Fields] OR ("review literature as topic"[MeSH] AND "systematic"[tiab]) 
OR "meta-analysis"[Publication Type] OR "meta-analysis as topic"[MeSH Terms] OR 
"meta-analysis"[All Fields] 
10 
4 1 AND "Case-Control Studies"[MeSH] OR "Cohort Studies"[MeSH] OR 
"Epidemiologic Studies"[MeSH] OR "Cross-Sectional Studies"[MeSH] OR 
"Organizational Case Studies"[MeSH] OR "Cross-Over Studies"[MeSH] OR "Follow-
Up Studies"[MeSH] OR "Seroepidemiologic Studies"[MeSH] OR "Evaluation 
Studies"[Publication Type] OR “observational study” OR “observational studies”  
148 
5 1 AND ((("semi-structured" or semistructured or unstructured or informal or "in-
depth" or indepth or "face-to-face" or structured or guide) adj3 (interview* or 
discussion* or questionnaire*))).ti,ab. 
0 
6 1 AND evaluation studies/ or evaluation studies as topic/ or program evaluation/ or 
validation studies as topic/ or ((pre- adj5 post-) or (pretest adj5 posttest) or 
(program* adj6 evaluat*)).ti,ab. or (effectiveness or intervention).ti,ab. 
0 
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Figure 1. PRISMA figure on disposition of articles 
 
 
 
 
 
 
 
 
 
 
 
 27 
Table 3. Evidence Table of studies. 
 
Study Characteristics Design F/u time (months)   n Effect on social isolation 
Grant et al., 2000 
Amalthea Project program in 26 
general practices in Avon, UK. 
Referral facilitators assessed pts 
and recommended voluntary 
sector resources. 
RCT 4 161 Non-significant reduction  
Kimberlee, 2016 
Wellbeing Programme at the 
Wellspring Healthy Living Center 
five GP surgeries in Bristol, UK. Pt 
assessment and linkage to 
community (cooking classes, 
men’s groups, Somali outreach). 
Pre/post 3 69 Significant reduction 
Moffatt/Wildman 
et al., 2017/19 
Ways to Wellness program across 
17 practices in Newcastle upon 
Tyne, UK. Link worker 
assessment, community linkage 
(i.e. welfare rights advice, 
walking groups, physical activity 
classes, arts groups, continuing 
education), and promotion of 
volunteering. 
Pre/post >4 24 No effect  
Potter, 2013 
Arts on Prescription, a 12-week 
program featuring an array of 
visual arts activities (i.e. drawing, 
collage, stitching); delivered by 
an artist and a mental health 
counselor  
Pre/post 3 26 Non-significant reduction 
Potter, 2015 Pre/post 3 45 Significant increase 
Rotherham, 2014 
Rotherham Social Prescribing 
Pilot program, featuring 31 
distinct SP services in partnership 
with 24 grant-receiving 
community organizations. 
Frequently linked resources 
include community activity, 
physical activity, befriending, and 
enabling.” 
Pre/post 4 280 Non-significant reduction 
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Table 4. Methodology used to measure social isolation by study. 
Study How was Outcome measured? 
Grant et al. Duke-UNC Functional Social Support Scale  (8 items; Confidant and Affective Support) 
Kimberlee Friendship Scale (5 items) 
Moffatt/Wildman et al. Composite MH question: “Have you experienced low mood, anxiety, depression, loneliness, or social isolation?” 
Potter, 2013 
Not provided 
Potter, 2015 
Rotherham Asked to rate “connectedness to family and friends” on a 1-5 scale 
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Appendix B – Interview Materials 
 
Recruitment Email 
 
Hello [Subject’s Name], 
 
My name is Zachary McDonald, and I am a medical student at the University of North Carolina-
Chapel Hill working toward my Master in Public Health this year. 
 
I am writing to ask if you would agree to participate in a phone or videoconference interview for 
my Master’s Paper project. I am conducting a policy analysis on the feasibility of an expansion 
of social prescribing schemes in the United States, with special attention to its capacity to reduce 
loneliness and social isolation. The aims of my analysis are three-fold: (1) to trace the origins of 
social prescribing policy in the U.K. and its avenues of international dissemination, as well as 
characterize its present status on the legislative agendas of high-income countries; (2) to identify 
strong predictors of pilot program success and the populations best positioned to benefit from 
these schemes; and (3) to consider the capacities of various payers to fund these schemes (i.e. 
insurers, consumers, and the philanthropic sector) in the context of recent health reforms.   
 
I have a set of questions already drafted for you that are specific to your expertise in this area. 
My interview would last approximately 30 minutes. 
 
My faculty advisor is Dr. Sue Tolleson-Rinehart in the Department of Pediatrics, and you are 
welcome to contact her at any time about this project. Her e-mail is suetr@unc.edu.  
 
The UNC IRB has reviewed this study (#19-0933). It is exempted from full review and has been 
deemed Non-Human Subjects Research.  
 
If you agree to participate, I will work to schedule a time that is convenient for you. Just prior to 
our conversation, I will ask for your verbal consent to be interviewed, recorded, and identified by 
name and title, in accordance with standard practice at my university. You will have the option 
of remaining anonymous. 
 
Please do not hesitate to reach out by phone or e-mail with any questions about my request. 
 
Sincerely, 
 
Zachary McDonald 
 
MD Candidate, Class of 2020 
UNC School of Medicine 
MPH Candidate, Class of 2019 
UNC Gillings School of Global Public Health 
zacharyl@med.unc.edu | 580.656.3188 
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Interview Protocol  
 
Hello, my name is Zack McDonald. I’m a medical student at UNC-Chapel Hill working toward 
my Master in Public Health this year. I’m here to facilitate a conversation about the status of 
social prescribing schemes in the United States. For my Master’s Paper project, I am conducting 
a policy analysis to explore the feasibility of the expansion of these programs into new sectors of 
the American health system. Thanks for making time for this discussion today. 
 
My faculty advisor is Dr. Sue Tolleson-Rinehart in the Department of Pediatrics, and you are 
welcome to contact her at any time about this project. Her e-mail is suetr@unc.edu. The UNC 
IRB has exempted this study from full review. It has been deemed NHSR.  
 
Before we begin, could you give me your verbal consent to be interviewed? 
 
 Interviewee CONSENTS to being interviewed. 
 Interviewee DECLINES to be interviewed. 
 
[Assuming consent granted] Great. With your permission, I will be recording our conversation in 
order to make sure I have an accurate record of what you have told me.   
 
Do you also consent to being recorded? At your request, I can provide you with a full transcript. 
 
 Interviewee CONSENTS to be recorded 
 Interviewee DECLINES to be recorded (my notes will be sole record). 
 
Finally, I would prefer to identify you by name and position in the course of my project in order 
to strengthen the credibility of the research. If you prefer to remain anonymous, however, I will 
simply note your general title, such as “attending physician,” “non-profit executive,” or “health 
policy expert.” 
 
Do you consent to be identified by name?   YES             NO 
 
 
Thank you! Do you have any questions before we get started? 
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Sample Interview Guide 
 
1. I’d like to start by discussing the state of federal policy to address social needs. Which 
approaches, if any, are gaining legislative traction right now?  
 
2. Are there particular states that have passed innovative policy in this area?  
 
3. Do you see federal or state funding for social services expanding or contracting over the 
near term? The long term? 
 
4.  Describe your personal experience with social prescribing schemes. In your view, which 
social issues can they best address, if any? 
 
5. What is the most evidence-based (and/or most common) model of community referral 
used in the primary care setting in the United States today? 
 
6. Are there social prescribing schemes within certain local or regional health systems that 
are able to offer a wide array of services? If so, where? 
 
7. Do you see social prescribing expanding in the United States over the next decade? If so, 
where? Who are its chief proponents? Which factors may impede progress here? 
 
8. What lessons can America learn from the UK’s experimentation with these schemes? I’m 
asking this of all of my interview subjects. 
 
9. Where should the public health threat posed by loneliness and social isolation lie on our 
national priority list? What are the best social interventions for this issue? 
 
